Preview

Problems of Endocrinology

Advanced search

Charity Program «Alfa-Endo» for children with endocrine disease

https://doi.org/10.14341/probl201561250-54

Abstract

Charity program to help children with endocrine diseases «Alpha-Endo” is aiming to improve quality of medical care for children with endocrine pathology. The main directions of the Program include: molecular-genetic and immunological testing of hereditary endocrine diseases; improvement of health and social care for children; and obesity prevention. The best evidence-based Russian and international managerial strategies, and clinical practices of diagnostics, prevention and treatment of endocrine diseases are reviewed by experts and implemented within the Program. The synergistic cooperation involving the highly qualified Endocrinology Research Centre staff, significant financial resources “Alfa Group” and organizational support of CAF Foundation helps to solve difficult problems in pediatric endocrinology and improve welfare of children with endocrine diseases.

About the Authors

I I Dedov
Endocrinology Research Centre, Moscow


V A Peterkova
Endocrinology Research Centre, Moscow


A V Karpushkina
The «CAF» Foundation for Fhilantropy Support and Development, Moscow


References

1. Dionisi-Vici С, Rizzo С, Burlina АВ. et al. Inborn errors of metabolosm in the Italian pediatric population: A national retrospective survey. // The Journal of Pediatrics. 2002;140(3):321-329. doi: 10.1067/mpd.2002.122394.

2. Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and social issue. // The Lancet. 2008;371(9629):2039-2041. doi: 10.1016/s0140-6736(08)60872-7.

3. van Weely S, Leufkens HGM. Orphan diseases. Background paper. In: priority medicines for Europe and the world. A public health approach to innovation. http://mednet3.who. int/prioritymeds/report/index.htm#c.

4. Eurordis. EurordisCare2: survey of diagnostic delays, 8 diseases, Europe, http://www.eurordis.org/big_article.php37id_article=454.

5. Форум доноров. Доклад о состоянии и развитии фондов в России. 2013. Доступно по ссылке URL: http://www.donorsforurn.ru/materials/doklad-o-sostoyanii-i-razvitii-fondov-v-rossii.

6. ВОЗ. Здоровье-2020: основы Европейской политики в поддержку действий всего государства и общества в интересах здоровья и благополучия. Доступно по ссылке URL: http://www.euro.who.int/_data/assets/pdf_file/0018/215433/Health2020-Short-Rus.pdf?ud=1

7. Medicines and Healthcare Products Regulatory. Good Laboratory Practice. http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodLaboratoryPractice/ind ex.htm.

8. Национальный стандарт РФ ГОСТ Р 53022.1-2008 «Технологии лабораторные клинические. Требования к качеству клинических лабораторных исследований. Часть 1. Правила менеджмента качества клинических лабораторных исследований (утвержден Приказом Ростехрегулирования №355-ст от 04.12.08

9. Hofgartner WT, Tait JF. Characteristics of clinical molecular-genetic testing laboratories in the United States. // Clin Chem. 1999;45:1288-1290.

10. McGovern MM, Elies R, Beretta I. et al. Report of an International Survey of Molecular Genetic Testing Laboratories. // Community Genetics. 2007;10(3):123-131. doi:10.1159/000101753.

11. Hudson KL, Murphy JA, Kaufman DJ. et al. Oversight of US genetic tsting laboratories. // Nature Biotechnology. 2006;24(9):1083-1090. doi: 10.1038/nbt0906-1083.

12. McGovern MM. Quality Assurance in Molocular Genetic testing Laboratories. // JAMA. 1999;281(9):835. doi: 10.1001/jama.281.9.835.

13. McGovern MM, Benach M, Wallenstein S. et al. Personnel standards and quality assurance practices of biochemical genetic testing laboratories in the United States. // Arch Pathol Lab Med. 2003;127(l):71-76. doi: 10.1043/0003-9985(2003) 127<71:PSAQAP>2.0.CO;2.

14. Howanitz PJ, Tetrault GA, Steindel SJ. Clinical laboratory quality control: a costly process now out of control. // Clinica Chimica Acta. 1997;260(2): 163-174. doi: 10.1016/s0009-8981(96)06494-7.

15. McGovern MM, Elies R, Beretta I. et al. Report of an International Survey of Molecular Genetic Testing Laboratories. // Community Genetics. 2007;10(3):123-131. doi: 10.1159/000101753.

16. Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions.

17. Guidelines for Quality Assurance in Molecular Genetic Testing.

18. Provost LP, Murray S. The Health Care Data Guide: Learning from Data for Improvement. - 2011, Jossey-Bass.

19. Shaw C, Kalo I. A backgroum for national quality policies in health systems. - Copenhagen, WHO Regional Office for Europe. 2002.

20. Scott I. What are the most effective strategies for improving quality and safety of health care? // Internal Medicine Journal. 2009;39(6):389-400. doi: 10.1111/j.1445-5994.2008.01798.x.

21. Farrow R, Norman G. The effectiveness of PBL: the debate continues. Is metaanalysis helpful? // Medical Education. 2003;37(12):1131-1132. doi: 10.1046/j/1365-2923.2003.01725.x.

22. Neville AJ. Problem-based learning and medical education forty years on. A review of its effects on knowledge and clinical performance. // Med Princ Pract. 2009;18(1):1-9. doi:10.1159/000163038.

23. Sanson-Fisher RW, Lynagh MC. Problem-basec learning: a dissemination success story? // Med J Aust. 2005;183(5):258-260.

24. Cantillon P. Teaching large groups. // BMJ. 2003;326(7386):437. doi:10.1136/bmj.326.7386.437.

25. Jaques D. ABC of learning and teaching in medicine: Teaching small groups. // BMJ. 2003;326(7387):492-494. doi: 10.1136/bmj.326.7387.492.

26. Michael J. Where’s the evidence that active learing works? // Adv Physiol Educt. 2006;30:159-167.

27. Michaelsen LK, Fink LD. Team-based Learning: Small group learning’s next big step. // New Directions for Teaching and Learning. 2008;116:1-104.

28. Norman G. What’s the active ingredient in active learning? // Adv Health Sci Educ Theory Pract. 2004;9(l):l-3.

29. Scott I. What are the most effective strategies for improving quality and safety of health care. // Internal Medicine Journal.2009;39:389-400.

30. Diabetes UK (2005) Resources to support the delivery of care for children and young people with Diabetes. Доступно по ссылке URL http://www.diabetes.org.uk/Documents/Shared%20pra %2006.pdf.

31. Guidance on the use of patient-education models for diabetes. 2008.

32. Interventions for preventing obesity in children. Cochrane Public Health Grpup.


Review

For citations:


Dedov I.I., Peterkova V.A., Karpushkina A.V. Charity Program «Alfa-Endo» for children with endocrine disease. Problems of Endocrinology. 2015;61(2):50-54. (In Russ.) https://doi.org/10.14341/probl201561250-54

Views: 1042


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)